Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
184A1
NM
Basal
Geldanamycin
HSP90
HSP90
10002.012
uM
0.00232
0.00278
-0.4963 -0.4694 3.6140 1.2014
0.9946
0.5807
184B5
NM
Basal
Imatinib
ABL/KIT/PDGFR
nRTK
5896.091
uM
23.18150
34.00000
-0.9493 -0.9584 2.7948 0.4637
0.9940
1.4988
184A1
NM
Basal
PD173074
FGFR1/3
RTK
5895.093
uM
8.46530
9.95550
-0.0760 -0.1823 1.9169 0.0959
0.9866
1.3259
HCC2185
TNBC
Luminal
Doxorubicin
TOP2
TOP
10263.034
uM
0.02525
0.11148
-1.0000 -1.0000 0.7398 1.0785
0.9792
0.3750
HCC2185
TNBC
Luminal
GSK461364
PLK1
PLK
7849.001
uM
0.00104
0.00115
-0.9115 -0.3518 5.0000 1.0464
0.8751
0.5308
184A1
NM
Basal
PD184352
MEK
MAPK
12509.155
uM
8.55920
48.2470
0.1172 -1.0000 0.6353 0.1432
0.9509
1.3444
HCC2185
TNBC
Luminal
GSK461364
PLK1
PLK
7848.001
uM
0.00690
0.01004
-0.7963 -0.4889 1.8144 0.9258
0.9490
0.4548
184A1
NM
Basal
Afatinib
EGFR/HER2
ErbB
12509.165
uM
0.02251
0.33740
-0.9088 -1.0000 0.4058 0.8284
0.9307
1.5022
184A1
NM
Basal
Cisplatin
DNA cross-linker
DNA cross-linker
10002.021
uM
2.61470
4.77760
-0.9719 -0.9559 1.7730 0.6305
0.9959
0.7195
184A1
NM
Basal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
5895.095
uM
0.40767
0.41810
-0.0165 -0.0219 1.6956 0.7104
0.9924
1.4629
HCC2185
TNBC
Luminal
CPT-11
TOP1
TOP
10263.034
uM
1.76130
2.7730
-0.5448 -0.5665 1.6689 0.4269
0.9813
0.3750
HCC2185
TNBC
Luminal
Docetaxel
TUBB
TUBB
7848.002
uM
0.00176
0.00217
-0.0325 -0.1015 0.8880 0.7481
0.9274
0.5588
HCC2185
TNBC
Luminal
Etoposide
TOP2
TOP
7464.074
uM
6.93160
44.65820
-0.5404 -1.0000 0.5897 0.3827
0.9952
0.5504
HCC2185
TNBC
Luminal
Geldanamycin
HSP90
HSP90
7849.04
uM
0.01717
0.02311
-0.8205 -0.7965 3.2059 1.1738
0.9991
0.5448
HCC2185
TNBC
Luminal
GSK1070916
AURK
AURK
7848.001
uM
0.23168
2.21180
-0.7395 -1.0000 0.4869 0.5192
0.9120
0.4548
184A1
NM
Basal
PS-1145
IKK
NFKB
5895.065
uM
inf
inf
1.0031 1.0031 0.0000 -0.0389
-4.6402
1.3748
HCC2185
TNBC
Luminal
GSK1070916
AURK
AURK
7849.001
uM
0.52517
4.12770
-0.6199 -1.0000 0.5329 0.4275
0.9620
0.5308
HCC2185
TNBC
Luminal
GSK1070916
AURK
AURK
9420.001
uM
0.03883
0.83363
-0.8630 -1.0000 0.3583 0.6662
0.8579
0.3332
184A1
NM
Basal
Purvalanol A
CDK1
CDK
5895.067
uM
51.18430
39.92310
0.3558 0.3553 4.9894 0.0457
0.9764
1.4053
184A1
NM
Basal
GSK1070916
AURK
AURK
9047.001
uM
0.83697
5.25260
-0.4457 -0.9735 0.5885 0.3812
0.9828
0.7701
HCC2185
TNBC
Luminal
Fascaplysin
CDK4
CDK
7462.085
uM
0.01916
0.07622
-1.0000 -1.0000 0.7956 0.9867
0.9706
0.3896
HCC2185
TNBC
Luminal
Gemcitabine
DNA replication
DNA replication
7849.011
uM
0.03116
0.02711
-0.0746 0.1113 1.8071 0.5893
0.9120
0.5467
HCC2185
TNBC
Luminal
GSK1070916
AURK
AURK
10263.001
uM
0.14569
3.45390
-0.4750 -1.0000 0.3470 0.5409
0.8338
0.3258
184A1
NM
Basal
SB-3CT
MMP2/9
MMP
12509.168
uM
433.25760
1000.00000
0.6180 -0.2672 0.5118 0.0585
0.8869
1.3516
HCC2185
TNBC
Luminal
Gefitinib
EGFR
ErbB
7848.016
uM
162.91990
51.17650
0.6991 0.2901 0.7496 0.0336
0.7573
0.4818